Etiologies And Predictors Of 30-Day Readmission In Patients Undergoing Induction Chemotherapy For Acute Myeloid Leukemia

Introduction: Early readmissions are important indicators of quality of health-care. National-level data is currently lacking for patients admitted for induction chemotherapy for acute myeloid leukemia (AML). Our study is to investigate characteristics and predictors of 30-day hospital readmission in patients with AML after receiving induction chemotherapy.